A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis

K. A. Papp^*, K. Reich, C. Paul, A. Blauvelt, W. Baran, C. Bolduc, D. Toth, R. G. Langley, J. Cather, A. B. Gottlieb, D. Thaçi, J. G. Krueger, C. B. Russell, C. E. Milmont, J. Li, P. A. Klekotka, G. Kricorian, A. Nirula

^*Corresponding author for this work